Published 2006 | Version v1
Miscellaneous Restricted

The international dosimetry exchange for BNCT. A basis for pooling and collectively analyzing clinical results

  • 1. Nuclear Reactor Laboratory, Massachusetts Institute of Technology, Cambridge, MA (United States)
  • 2. Dept. of Nuclear Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA (United States)
  • 3. Dept. of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (United States)
  • 4. Boneca Ltd., HUS Helsinki (Finland)
  • 5. European Commission Joint Research Center, Petten (Netherlands)
  • 6. Nuclear Research Inst., Rez (Czech Republic)
  • 7. Studsvik Medical AB, Nykoeping (Sweden)

Description

An international collaboration was organized by the Massachusetts Institute of Technology (MIT) to undertake a dosimetry exchange for the eventual purpose of combining results from various clinical centers that employ different methods for measuring and prescribing absorbed dose in the mixed radiation fields used for neutron capture therapy. Treatment plans calculated at NCT centers in the Czech Republic, Finland, The Netherlands and Sweden were normalized to corresponding measurements performed by the MIT dosimetry group in each beam. More than half of the normalizations for individual absorbed dose components (photon, fast neutron, thermal neutron and boron) determined by comparing MIT measurements to the dose specified in treatment plans from the different centers were statistically significant and ranged from 8 to 400%. Each facility had at least one dose component that would require normalization for the specified doses to be accurately compared. These normalizations establish a technical basis to begin collectively analyzing treatment plans between the European and US centers. Simple but pertinent treatment parameters such as the maximum dose to brain can now be properly compared, once the clinical data is available. This could held to more precisely and quickly determine various dose-response relationships as for example those related to adverse events. Future efforts to determine dose normalization at other centers performing human studies as well as more sophisticated analyses using combined data from several centers should be guided by clearly defined clinical objectives with active participation from clinical BNCT experts. (author)

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Part of:
Advances in neutron capture therapy 2006. Proceedings of 12th international congress on neutron capture therapy

Additional details

Publishing Information

Imprint Title
Advances in neutron capture therapy 2006. Proceedings of 12th international congress on neutron capture therapy
Imprint Pagination
638 p.
Journal Page Range
p. 393-396
Report number
INIS-JP--103

Conference

Title
12. international congress on neutron capture therapy
Acronym
ICNCT-12
Dates
9-13 Oct 2006
Place
Takamatsu, Kagawa (Japan)

Optional Information

Notes
8 refs., 1 fig., 1 tab.